Industry News

Biological Dynamics, a multiomics liquid biopsy company focused on detecting cancers at the earliest stages, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for its liquid biopsy assay, Exo-PDAC...

Unique technology harnesses the promising diagnostic power of exosomes and demonstrates potential application for the detection of many...

Izon Science has announced the launch of Gen 2, the enhanced range of qEV columns for size-exclusion chromatography-based separation. The new range of qEV columns are made with a proprietary, agarose resin, which delivers a more purified extracellular vesicle (EV)-containing ...

A Korean genetic sequencing firm has taken a step towards the commercialization of its liquid biopsy technology, which aims at detecting early stage cancer with a simple blood test and suggesting optimized treatment. Eone Diagnomics Genome Center (EDGC) announced that ...

Creative Biolabs is a front runner deeply cultivated in the expertise of exosome research. It shows determination on advancing different applications of exosomes in disease prognosis, diagnosis, drug delivery, and vaccine development with comprehensive solutions, including isolation and characterization of ...

New publication demonstrates the ability to engineer exosomes to display specific protein receptors on their surface and through that optimisation achieve better efficacy relative to conventional biologics...

NanoView Biosciences today announced the release of the ExoView R200, its next-generation platform for the sensitive detection and characterization of extracellular vesicles (EVs), including exosomes and viruses. Launched in 2019, ExoView provides high...

Due to the small size of exosomes, their ease of production, and the fact that they are made from stem cells that are recognized by the FDA, we anticipate..

Creative Medical Technology Holdings announced today filing a new patent application covering nanoparticles called “exosomes” secreted by cells of its...

A new biotechnology company in Santa Fe is raising money for a platform designed to battle disease. The early-stage startup, called Spartina Biotechnologies, uses what are called exosomes to deliver genetic...